沉默的并发症:1型糖尿病儿科患者的听力功能障碍
Sara Shefa1, Aleksandra Głębocka1, Tetiana Zinyk1
1Student Scientific Association of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, 213 Borowska St., 50-556 Wrocław, Poland.
Journal of clinical medicine
|January 28, 2026
概括
患有1型糖尿病的儿童经常出现听力损失,特别是在高频率时,影响语音理解. 早期听力测量查对于在儿科糖尿病护理中管理这种听觉并发症至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 听力学 听力学是指听力学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 糖尿病会影响多个系统,但它对儿科听觉功能的影响尚不清楚.
- 儿童的听力障碍可以显著影响认知,语言和社会发展.
研究的目的:
- 确定糖尿病对儿童听觉功能的影响.
- 突出早期识别和管理儿童糖尿病患者的听力缺陷的重要性.
主要方法:
- 对1型糖尿病 (T1DM) 和儿童听觉功能的现有研究进行审查.
- 对高频率 (4000-8000 Hz) 的听力值和语音理解得分的分析.
主要成果:
- 与对照人群相比,患有T1DM的儿童表现出高频听力值升高和语音理解低下.
- 低血糖控制和更长的疾病持续时间与更糟糕的听觉结果相关.
- 微血管病变和神经病变是听觉通路损伤的拟议机制.
结论:
- 未诊断的听力障碍是糖尿病儿童的风险,因为没有报告的症状.
- 通过定期听力测量查进行早期检测对于儿科糖尿病护理至关重要.
- 查有助于预防对沟通和认知发展的不良影响.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
2.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism
213
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Diabetes Mellitus: Type 2 and Gestational
4.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
272
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272


